In-licensing: Academic/Research & Dermatological

Latest: Watch here for details of new products and services.

Our Products: Overview; Partnering Search; Company Profiling; Partneringtools; Reports; Partnering Consulting; Comparison
Forums: Visit our forums
Jobs: Visit our job site
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire New!
Contact us: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing Ltd
is a division of

Up-to-date access to technology licensing opportunities worldwide.

Displaying 1..3 of 3 - per page
Order by

New Products/Technologies for Acne in early to late phases or already marketed required for acquisition or in-licensing for Mexico More

NCEs for innovative therapeutic targets in inflammatory/immunologic diseases. More

New Products/technologies for Atopic Dermatitis in early to late phases or already marketed required for acquisition or in-licensing for Mexico More

Displaying 1..3 of 3 - per page
Order by

Industry sector: Animal health; Biotech; Diagnostic; Drug delivery; Medical device; Pharmaceutical
Therapeutic target: Acne; Actinic keratosis; Alopecia; Bacterial infection; Burns; Chronic idiopathic urticaria; Cosmetic procedures; Dermal ulcers; Dermatitis, allergic; Dermatitis, atopic; Dermatological (other); Dermatosis; Eczema; Fungal infection; Hirsutism; Human B19 parvovirus; Hyperkeratosis; Ichthyosis; Impetigo; Insect bite; Keloids; Lupus; Male pattern baldness; Paget's disease; Photodamage; Pruritis; Psoriasis; Scleroderma; Shingles; Skin infection (other); Ulcer, diabetic; Urticaria; Wound healing
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Industry news: Pharmalicensing provides comprehensive industry coverage.